Proto Labs Inc PRLB
NYSE · XNYS · stock · Fabricated Structural Metal Products
Chart by TradingView
6/9
Piotroski F — financial health
10.59
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $533.1M | $21.2M | $237.1M | $59.7M | $673.9M |
| 2024 | $500.9M | $16.6M | $223.2M | $68.7M | $670.2M |
| 2023 | $503.9M | $17.2M | $222.0M | $45.2M | $695.3M |
| 2022 | $488.4M | -$103.5M | $215.5M | $40.4M | $697.6M |
| 2021 | $488.1M | $33.4M | $222.7M | $21.0M | $828.5M |
| 2020 | $434.4M | $50.9M | $217.8M | $60.0M | $644.4M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 10.59 (safe)
- Working capital / assets 0.218
- Retained earnings / assets 0.315
- EBIT / assets 0.033
- Equity / liabilities 7.531
Source: SEC EDGAR filings · CIK 0001443669 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.